Measure Name:
Antiplatelet Medication for High Risk Patients
QCDR Measure ID:
PPRNET8
QCDR Measure Type:
Existing Approved QCDR Measure With No Changes
NQF ID Number (if applicable)
N/A
High Priority Type:
N/A
Measure Type:
Process
NQS Domain:
Effective Clinical Care
Inverse Measure?
No
Proportional Measure?
Yes
Continuous Variable Measure?
No
Ratio Measure?
No
Number of performance rates to be calculated and submitted in the XML:
1
Risk-Adjusted?
No
If risk-adjusted, indicate which score is risk-adjusted:
N/A
Measure Description:
The percentage of high risk patients who are prescribed an antiplatelet medication. High risk patients include those patients ages 50-69 years with ≥ 10% 10-year CVD risk
What one meaningful measure area applies to this measure?
Preventive Care
Rational:
Aspirin therapy for chemoprevention for adults who are at increased risk for CHD is a Grade A recommendation of the USPSTF. As secondary prevention, aspirin reduces the risk of subsequent myocardial infarction, stroke and vascular death
Denominator:
Patients ages 50-69 years old with a ≥ 10% 10-year CVD risk as defined by American College of Cardiology/American Heart Association Cholesterol Guidelines for ASCVD Risk Reduction in Adults Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd‐Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889‐934
Denominator Exclusions:
None
Numerator:
Patients with a current prescription for an antiplatelet medication
Numerator Exclusions:
None
Denominator Exceptions:
None